Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 09/10/20 → 07/10/25 |
Funding
- RevImmune SAS: $31,802.00
COVID-19 Clinical Research: Recombinant InterLeukin-7 (CYT107) to Improve Clinical Outcomes in Lymphopenic Patients with COVID-19 Infection "ILIAD 7 Trial"
- Abbasi, Sadia (PI)
- Nachman, Sharon (CoPI)
- Navetta, Brianne Nicole (CoPI)
- Kuperberg, Stephen (PI)
Project: Research